免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

臨床試驗

The Effect of Remifentanil on the Objectively Measured Pressure Pain Threshold

NCT:NCT07568405 · ENROLLING_BY_INVITATION

NCT IDNCT07568405
狀態ENROLLING_BY_INVITATION
開始日期2026-01-26
完成時間2026-06-15

簡要摘要

It is a clinical study investigating the relationship between objectively measured pain threshold and the need for escalating doses of remifentanyl opioids. This study is expected to include approximately 40 participants. The aim of the study is to objectively measure the analgesic effect of an increasing dose of opioids just before anesthesia.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。

↑